tiprankstipranks
Alcon Inc (GB:0A0D)
LSE:0A0D

Alcon (0A0D) Share Price & Analysis

1 Followers

0A0D Stock Chart & Stats

Day’s RangeCHF0 - CHF0
52-Week RangeCHF61.36 - CHF77.92
Previous CloseCHF72.38
Volume7.12K
Average Volume (3M)182.18K
Market Cap
CHF36.23B
Enterprise ValueCHF39.90B
Total Cash (Recent Filing)$1.10B
Total Debt (Recent Filing)$5.15B
Price to Earnings (P/E)40.8
Beta0.64
May 14, 2024
Next Dividend Ex-DateN/A
Dividend Yield0.27%
Share Statistics
EPS (TTM)1.77
Shares Outstanding499,700,000
10 Day Avg. Volume35,253
30 Day Avg. Volume182,175
Standard Deviation0.05
R-Squared0.19
Alpha0.00967
Financial Highlights & Ratios
Price to Book (P/B)36.31
Price to Sales (P/S)3.81
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue9.16
Enterprise Value/Gross Profit7.60
Enterprise Value/Ebitda42.32
Forecast
Price Target Upside16.10% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering18

Bulls Say, Bears Say

Bulls Say
Financial OutlookAnalyst sentiment is strong on Alcon's financial performance, with an increased Price Objective reflecting higher estimates and an anticipated revenue acceleration from equipment upgrades.
Innovation And Product LaunchAlcon's Unity VCS system is set to revolutionize the market with its smaller footprint, improved work efficiency, and cost advantage, offering a premium solution for users.
Market GrowthWith a promising outlook, Alcon (ALC) leads the way in the US AT-IOL market and is strategically expanding its presence to increase penetration in the United States.
Bears Say
Financial PerformanceThe analyst's estimates for adjusted EBIT are slightly below consensus for the coming quarter, indicating potential concerns about profitability.
Foreign Exchange ImpactManagement assumes foreign exchange rates as of the end of January will hold through year-end '24, estimating that FX may now represent headwinds of 60bps to sales.
Market CompetitionDoctors anticipate a modest market share erosion for ALC in AT-IOLs due to increased competition
---

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%25.46%15.10%59.44%
0.00%
Insiders
15.10% Other Institutional Investors
59.44% Public Companies and
Individual Investors

0A0D FAQ

What was Alcon Inc’s price range in the past 12 months?
Alcon Inc lowest share price was CHF61.36 and its highest was CHF77.92 in the past 12 months.
    What is Alcon Inc’s market cap?
    Currently, no data Available
    When is Alcon Inc’s upcoming earnings report date?
    Alcon Inc’s upcoming earnings report date is May 14, 2024 which is in 4 days.
      How were Alcon Inc’s earnings last quarter?
      Alcon Inc released its earnings results on Feb 27, 2024. The company reported CHF0.616 earnings per share for the quarter, beating the consensus estimate of CHF0.59 by CHF0.026.
        Is Alcon Inc overvalued?
        According to Wall Street analysts Alcon Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Alcon Inc pay dividends?
          Alcon Inc does not currently pay dividends.
          What is Alcon Inc’s EPS estimate?
          Alcon Inc’s EPS estimate is CHF0.65.
            How many shares outstanding does Alcon Inc have?
            Alcon Inc has 499,700,000 shares outstanding.
              What happened to Alcon Inc’s price movement after its last earnings report?
              Alcon Inc reported an EPS of CHF0.616 in its last earnings report, beating expectations of CHF0.59. Following the earnings report the stock price went up 4.237%.
                Which hedge fund is a major shareholder of Alcon Inc?
                Among the largest hedge funds holding Alcon Inc’s share is PRIMECAP Management Co. It holds Alcon Inc’s shares valued at 62M.
                  ---

                  Company Description

                  Alcon Inc

                  Alcon Inc. is a medical company which is specialized in eye care products. The company develops, manufactures, distributes, and sells technologies and devices for cataract, retinal, refractive surgery, as well as contact lenses and lens care products.
                  ---

                  0A0D Company Deck

                  ---

                  0A0D Earnings Call

                  Q4 2024
                  0:00 / 0:00
                  ---

                  0A0D Stock 12 Month Forecast

                  Average Price Target

                  CHF84.03
                  ▲(16.10% Upside)
                  {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"60":"CHF60","91":"CHF91","67.75":"CHF67.8","75.5":"CHF75.5","83.25":"CHF83.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":90.744,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">CHF90.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":84.028944,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">CHF84.03</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":61.9999997613744,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">CHF62.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[60,67.75,75.5,83.25,91],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2023","6":"Nov<br/>2023","9":"Feb<br/>2024","12":"May<br/>2024","25":"May<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,71.63,73.1003076923077,74.57061538461538,76.04092307692308,77.51123076923076,78.98153846153846,80.45184615384615,81.92215384615385,83.39246153846153,84.86276923076923,86.33307692307692,87.80338461538462,89.2736923076923,{"y":90.744,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,71.63,72.58376492307691,73.53752984615384,74.49129476923076,75.4450596923077,76.39882461538461,77.35258953846153,78.30635446153846,79.26011938461538,80.2138843076923,81.16764923076923,82.12141415384615,83.07517907692308,{"y":84.028944,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,71.63,70.88923075087494,70.1484615017499,69.40769225262486,68.66692300349982,67.92615375437477,67.18538450524971,66.44461525612468,65.70384600699963,64.96307675787457,64.22230750874954,63.481538259624486,62.74076901049944,{"y":61.9999997613744,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":64.951,"date":1683244800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.423,"date":1685664000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.107,"date":1688688000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.431,"date":1691107200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.2,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.454,"date":1696550400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.95,"date":1698969600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.948,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.072,"date":1704412800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.885,"date":1706832000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.616,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.875,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.63,"date":1714694400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Alcon
                  Bausch Health Companies
                  SAGE Therapeutics
                  Karyopharm Therapeutics
                  BioMarin Pharmaceutical
                  Popular Stocks
                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis